Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00204958Phase 4Completed
Phase 4 trial of glutamine in mucositis, sponsored by University of Wisconsin–Madison. Primary endpoint: Grade of Mucositis. Started Feb 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00204958.